A Case Report of Cardiac Arrest After Intravenous Administration of Sulfur Hexafluoride (Lumason®) Ultrasound Enhancing Agent

J Pharm Pract. 2024 Apr;37(2):509-512. doi: 10.1177/08971900231158935. Epub 2023 Feb 19.

Abstract

Ultrasound enhancing agents (UEAs) are medications that enable clear visualization of ultrasound images. While large studies have demonstrated the safety of these agents, case reports of life-threatening reactions temporally associated with their use have been published and reported to the Food and Drug Administration. Current literature describes the most serious adverse reactions due to UEAs to be allergic in nature; however, embolic phenomena may play a role as well. Here, we report a case of unexplained cardiac arrest following the administration of sulfur hexafluoride (Lumason®) in an adult inpatient undergoing echocardiography where resuscitative efforts were ultimately unsuccessful, and review possible mechanisms of cardiac arrest based on prior published literature.

Keywords: cardiac arrest; cardiac contrast; sulfur hexafluoride.

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Adult
  • Contrast Media / adverse effects
  • Heart Arrest* / chemically induced
  • Humans
  • Sulfur Hexafluoride* / adverse effects
  • Ultrasonography / methods

Substances

  • Sulfur Hexafluoride
  • Contrast Media